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Abstract 
Introduction: The United States aims to reach human papillomavirus (HPV) vaccine-induced 
herd immunity by having 80% of all age-eligible individuals complete the vaccine series.  
However, the US is far from reaching this goal, especially among rural, medically underserved 
populations. In these medically-underserved regions, pharmacies may serve as an additional 
location for HPV vaccination.  Little is known about rural caregivers’ willingness to have their 
HPV vaccine age-eligible children obtain this cancer-prevention resource from their local 
pharmacist.  
Methods: Researchers conducted 26 in-depth interviews with rural caregivers of HPV vaccine 
age-eligible children to explore their willingness for pharmacist-administered HPV vaccination 
and analyzed interview data using an inductive qualitative content analyses approach.  
Results: The majority of caregivers were unaware that pharmacists could offer adolescent 
vaccines.  However, most were willing to allow their children to receive the vaccine from this 
non-traditional source. Most caregivers’ concerns regarding vaccinations from pharmacists 
included necessitating proper pharmacist training and certifications to vaccinate against HPV as 
well as requiring the pharmacist to send vaccine records to the primary care doctor.  Caregivers 
did not believe that having a pharmacist administer the HPV vaccine would affect their 
relationship with their primary care provider.  In terms of health education about the HPV 
vaccine and about pharmacists’ ability to vaccinate, caregivers preferred print health education 
resources and were interested in also receiving health information via social media.  
Conclusion: This study highlighted ways to increase health education related to HPV vaccination 
and an alternative site to receive the HPV vaccine. Pharmacies may serve as an additional site 
to increase HPV vaccine initiation and completion.  
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Introduction 
Human Papillomavirus (HPV) causes over 30,000 cases of cancer in the U.S. per year.1 
Oncogenic HPV strains, most commonly Types 16 and 18, are responsible for the majority of 
HPV-related cancers which include roughly 70% of oropharyngeal, 91% of anal, 90% of cervical, 
75% of vaginal, 69% of vulvar, 63% of penile cancers.1  In rural regions of the U.S., incidence of 
HPV-related cancers, especially oropharyngeal cancer in both men and women is higher than 
the rest of the country.2 Further, cervical cancer is higher in the rural South and Midwest.2  
Most of these cancers can be prevented by the timely completion of a 9-valent HPV vaccine 
series.1,3-5  
To reach herd immunity against HPV Types 16 and 18 (and other oncogenic and non-cancer 
causing strains), Healthy People 2020 aims to increase HPV vaccination to 80% for boys and 
girls.6  As of 2017, however, only 44.3% of boys and 53.1% of girls between ages 13-17 years old 
completed the HPV vaccine series nationwide.7 Rates of vaccine completion were lower in rural 
areas, as evidenced by being 10 percentage points lower in vaccination completion as 
compared to rural adolescents’ urban counterparts, even after controlling for poverty.7 Studies 
have found that, among rural populations, the two greatest barriers to HPV vaccine uptake is 
lack of parental awareness of HPV and the HPV vaccine 8,9 and also lack of a strong healthcare 
provider recommendation to receive the vaccine, resulting in missed clinical opportunities.9,10  
Traditionally, primary care providers (PCPs) such as pediatricians, family medicine physicians, 
nurse practitioners, and other nursing staff administer HPV vaccine doses. After individuals 
receive the first HPV vaccine dose from their PCP, they must return to their primary care clinic 
for additional doses. This places a burden on patients and their caregivers to schedule and 
attend additional, non-routine clinical visits.11-13 However, PCPs are not the only providers who 
can administer the HPV vaccine. Pharmacists can administer additional vaccine doses,14,15 and 
pharmacies may be able to serve as additional HPV vaccination sites, especially in medically 
underserved regions.  
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The Presidents’ Cancer Panel on Accelerating HPV Vaccine Uptake and the Pediatric Pharmacy 
Advocacy Group both recommend incorporating pharmacists to aid in HPV vaccine promotion, 
administration, and series completion.14,16 Pharmacists are trusted health care providers, cited 
as the second most-trusted health care professionals (after nurses)17 and community 
pharmacists are additionally cited as the most accessible providers. This in part is because 
pharmacies are more geographically dispersed than primary care clinics, offer more hours of 
availability, and appointments are not required to receive medical attention.18-20 Receiving 
vaccines at a pharmacy may help overcome structural patient-level barriers (e.g. time, 
transportation, additional co-pays) to receiving HPV vaccine doses. 21  
Little is known about rural caregivers’ willingness to have their adolescents receive 
vaccinations, particularly the HPV vaccine from their community pharmacists.  Further, little is 
known about how receiving vaccines from a community pharmacist may impact caregivers’ 
primary care-seeking behaviors for their adoloescents.22 Therefore, this qualitative study seeks 
to explore rural caregivers’ (of HPV vaccine age-eligible minors) perceptions of receiving the 
HPV vaccine from their local pharmacist.  
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Methods 
After the study received IRB approval, participants were recruited using a variety of methods.  
Study recruitment flyers were emailed to Area Health Education Centers’ listservs and to public 
libraries, asking the libraries to post the flyers on their community boards. Health fairs were 
attended and interviews for potential participants were scheduled.  Participants who received 
the study flier called the first author’s office phone to screen for eligibility and schedule a time 
for the in-depth interview.   
Verbal informed consent was obtained from all study participants prior to conducting the in-
depth interview.  Interview discussions were guided by an in-depth interview guide to structure 
the discussion related to caregivers’ perceptions of receiving adolescent vaccinations, 
particularly the HPV vaccine, with their community retail pharmacists.  (See Table 1 for a list of 
the interview questions.)  On average, interviews lasted 15 minutes.  Based on their preference 
all participants were either emailed an e-gift card or mailed a physical gift card for $20 as 
remuneration for their study participation.  
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Table 1: Interview Guide 
Introduction: 
Thank you for taking the time to take part in this interview.  These interviews will be used to 
get a better understanding of what you think about the Human Papillomavirus (HPV) vaccine. 
If you have any questions about the vaccine, I would be happy to discuss more health 
information at the end of the interview.  The purpose of this study is simply to explore your 
ideas and perceptions about the administration of the HPV vaccine. 
 
We hope to use findings from this study in future work to help prevent cancer.   
 
To start, I will ask you some questions about the Human Papillomavirus, called HPV for short. 
• What have you heard about the virus HPV? 
• How and where did you find out this information? 
• How do you think your child or children could be affected by HPV? 
My next set of questions relate to the HPV vaccine. 
• What have you heard about the HPV vaccine? 
• Where did you hear about it? 
• Have your children received the HPV vaccine? 
• Who administered the vaccine? 
 Was it your pediatrician? Family care healthcare provider? A healthcare 
provider from your child’s school? A different provider?  
• How many doses of the vaccine did your child receive? 
• Do you know if your child finished the vaccine series? 
• What do you think influences people to have their children vaccinated against HPV? 
• What may keep parents and caregivers from having their children vaccinated against 
HPV? 
• Is there anything else? 
• If possible, would you be willing to have your child receive vaccines from your 
community pharmacist? 
• What would influence you to seek the vaccine with your pharmacist? 
• Do you think that if your child received vaccines (in general) from your 
community pharmacist that this would impact how often you see your child’s 
primary care provider? 
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• What other information about the HPV vaccine would you like to share? 
• If we were going to conduct a program to increase HPV vaccination understanding - 
including the role of the pharmacist - what should that look like? 
• What type of format would be most engaging? (e.g. flier, photo novella, iPad 
based animation, etc.) 
• What type of media channel would be best to send the message (e.g. distributed 
at health clinics, via social media, poster, etc.) 
• Do you have any other recommendations for how best to share information about the 
HPV vaccine? 
 
Thank you for taking the time to speak with me about your experiences and perceptions 
about the HPV vaccine.  I certainly appreciate your valuable input.  This ends our interview.   
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All interviews were audio-recorded on a digital recorder and then uploaded to a professional 
transcription company’s website for verbatim transcription as the interviews were conducted. 
Upon receiving the interview transcripts, the typed files were compared to the audio MP3s to 
ensure transcription accuracy. Using an inductive approach,23 the researchers separately read 
the same three interview transcripts (selected due to their differing perspectives) prior to 
meeting in person to create and pilot a draft coding guide.  The coding guide included potential 
interview themes and definitions for each theme. These two research team members used the 
new coding guide to independently code three interview transcripts before meeting to 
compare codes.  Whenever new themes emerged from the data (and later from new interview 
transcripts), the research team members alerted one another of the new code and recoded all 
interviews based on the emergence of the new code.  This iterative approach increased the 
rigor of qualitative coding.24 All coding discrepancies were identified and intercoder agreement 
was assessed using ATLAS.ti software, which generates a score used to assess research 
members’ coding similarities.25 Prior to continuing to code the interview data, the researchers 
met to discuss coding discrepancies and how to expand or change the codebook definitions to 
ensure coding clarity.  The authors split the remaining interview transcripts, separately hand-
coded them, and the coded transcripts were entered into ATLAS.ti software. Upon completing 
interview coding, the authors met periodically to discuss their results and to select 
representative quotes that illustrate interview themes.24  
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Results 
 ATLAS.ti software found acceptable levels of agreement (Krippendorff cα =0.805) 
between the two researchers’ coding behaviors. 
Participant demographics can be found in Table 2. 
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Table 2: Participant Demographics 
Participants (N=26) 
Sex Female: 26 
Age (years) 
18-29: 3 
30-49: 19 
50-64: 4 
Race 
Black/African American:  1 
Hispanic/Latino American: 3 
Native American: 2 
Black/Native American: 1 
White Caucasian: 19 
Education 
Some high school: 3 
High school graduate: 7 
Some college: 6 
Trade/technical/vocational training: 1 
College graduate: 5 
Postgraduate degree: 4 
Employment 
Full-time: 12 
Part-time: 2 
Not employed: 9 
Retired: 1 
Unable to work: 1 
Other: 1 
Income (dollars) 
0 - 25,999: 7 
26,000 - 51,999: 5 
52,000 - 74,999: 8 
More than 75,000: 3 
Do not know: 2 
Decline to say: 1 
HPV vaccine behavior and 
intention  
At least one child initiated the vaccine series: 11 
Completed the vaccine series: 5 
Unsure of vaccine completion, but sure of initiation: 4 
Lacked clear response of initiation or completion: 2 
Intention to vaccinate child against HPV: 1 
Unsure/still deciding: 2 
No intention to vaccinate child against HPV: 9  
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The research team conducted interviews until they reached data saturation, and after 26 
interviews, they found that no new themes emerged from interview data.26  See Table 2 for 
participants’ demographic information and for HPV vaccine behavior. Themes that emerged 
from interview data include knowledge and awareness about the HPV vaccine, HPV vaccine 
behaviors and perceptions (which includes vaccine barriers and facilitators), attitudes related to 
pharmacists’ administration of the HPV vaccine, and health education preferences.  For the 
purpose of this paper, authors will focus on HPV vaccine barriers, willingness to receive a 
vaccine from a pharmacist, and ways this may impact caregivers’ relationship with their child’s 
primary care provider.  
HPV Vaccine Barriers 
The most commonly cited barrier to the HPV vaccine was fear of adverse reactions to the 
vaccine, a concern cited by eleven participants. One caregiver stated that she had read an 
article about cases where children have died after being vaccinated against HPV (Caregiver 16). 
Two caregivers reported that fear that vaccination can lead to the development of autism 
prevents caregivers from having their children vaccinated (in general).   
“[There are] things in the vaccines that, in the long run, will harm them. I have 
one friend who thinks that’s there is mercury in the vaccines, or that the 
government is doing unknown testing [on populations] through vaccines. And so, 
there are some interesting people out there that have their own ideas about 
what vaccinations do…like the MMR with autism.” (Caregiver 11) 
Another caregiver expressed distaste and lack of perceived need for all vaccines.  This caregiver 
responded: 
 “I just don’t like them (vaccines). I just don’t care for them to have them just because of 
things I’ve read. And I grew up without hardly any of them [any vaccines]. And I got the 
measles and the mumps, and I survived.” (Caregiver 9) 
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More often participants who lived in northern regions of the state described how their 
communities are religious and socially conservative. In these areas, they believed, the HPV 
vaccine is viewed as a resource that encourages children and adolescents to engage in 
premarital sex. One caregiver (Caregiver 14) even described that the HPV vaccine was 
nicknamed “the slut shot” in her community.  Other parents did not perceive the need for their 
children to be vaccinated against HPV because they are not sexually active and will remain 
abstinent.  
Attitudes Related to Pharmacists’ Administration of the HPV Vaccine 
The majority (n=18) of participants were willing to have their child or children receive the HPV 
vaccine or other adolescent vaccinations from their community retail pharmacist. Caregivers 
described that this method of receiving adolescent vaccinations could be a more convenient 
method to receiving the vaccine as opposed to relying on their primary healthcare providers, 
alone, for their children’s vaccinations.  There were various reasons why parents believed that 
this method of vaccine delivery is considered convenient. For one, caregivers would not have to 
schedule medical appointments with their primary care provider for their children to receive 
vaccines and vaccine booster doses 
“Sometimes in certain instances, it [getting the vaccine from the community 
pharmacist] may be even more convenient because of appointments [not having 
to make or keep appointments]. You know, trying to get into, you know, the 
doctor, the pediatrician, it’s like I’m scheduling it two weeks out unless my kids 
are sick and then it’s like I could just take them to urgent care or something.” 
(Caregiver 5)  
Another described how taking their children to the pharmacist for vaccinations may be more 
cost-effective as opposed to obtaining the additional booster doses with their primary care 
provider.  This additional visit may entail an additional copay; therefore, the participant 
believed, pharmacist-administrated vaccines may be more cost effective.   
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“For me it would most likely be cost: if they were charging me $10.00 per vaccine 
at the pharmacy, and I have to pay a $20.00 co-pay at the doctor’s office.” 
(Caregiver 13). 
Some parents also described how receiving vaccines from the local pharmacist may also 
relieve healthcare practitioners’ workload, making this form of vaccine administration 
more convenient for healthcare providers and for the community, as a whole. 
“You know what? I don’t see any problem with that as long as they’re qualified for 
that, and it would make things run a lot smoother for our community, for our 
hospitals, because we’re a big tribe and it’s always packed in the doctor’s office, 
or the pharmacy, everyone’s waiting around, there’s a lot of people.” (Caregiver 4) 
The most commonly reported stipulation to receiving the HPV vaccine from pharmacists (as 
opposed to primary care providers) related to pharmacists’ training and qualification to 
administer vaccines.  One caregiver responded, “If I knew that they were qualified for it and 
had all the certifications and everything like that, yeah. I don’t see why not.” (Caregiver 10). 
Another caregiver described being open to having their children receive vaccine from 
pharmacists as long as they followed the necessary standard protocols to vaccine 
administration and reporting.   
“As long as it’s done with the requirements that they would normally do at a doctor’s 
office… you know the cleanliness, the papers that need to be filled out, the records 
that need to be kept or whatever…” (Caregiver 17) 
Six participants stated that they would not have their children receive the HPV vaccine with 
their pharmacist, preferring form their child’s primary care provider administer the vaccine. 
This was often due to their stronger relationship with their primary care provider.  For example, 
a participant described her preference to get vaccines from her primary care provider “mostly 
because they know my family.” (Caregiver 6). Other caregivers expressed concerns that their 
children’s health records (with their primary care providers) may not be updated if another 
healthcare provider (other than the primary care provider) administered their child’s vaccines. 
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When asked how receiving adolescent vaccines would impact parents’ primary-care seeking 
behaviors for their children, the majority of parents described that it would not impact their 
relationship with their primary care provider.  One caregiver noted,  
“No [it wouldn’t affect how often we see our PCP]. We get care wherever we can, the 
cheapest way we can, and especially nowadays everything’s recorded – especially 
vaccines – at least in the State of Arizona. So, I guess if it’s not recorded, it’s just the 
parents’ responsibility to make sure they keep a record of it.” (Caregiver 18)  
Health Education Preferences 
When asked about the best ways to disseminate information about the HPV vaccine and about 
pharmacists’ ability to vaccinate, caregivers more often preferred receiving this information 
print fliers disseminated in various locations. More than half of all interview participants 
recommended creating brief information sheets about HPV to post at the local post office or to 
place in community members’ mailboxes.  They also recommended disseminating information 
about the HPV vaccine both at medical clinics as well as at pharmacies.     
The other most commonly promoted health education channel for HPV vaccine information 
was the social media site Facebook.   
“Most of the people here are on Facebook so, and some on Snapchat… I don’t 
know if it was really like vaccines or anything, but I know that they do [advertise] 
health physicals, that they do all-day things to where you can come in and get all 
your physicals done, and stuff like that, and I know they do [promote]  that on 
social media a lot.” (Caregiver 12) 
Additionally, participants described the use of Facebook pages for their community as 
places where they receive information about ongoing events in the community including 
health-related events.   
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“I would say that – yea, there is one for the city of (name of city), too. A general 
community Facebook page. I think that also would be another good idea of getting the 
word out there of the kind of like health – or what’d you say or kind of reminder.” 
(Caregiver 22) 
Other recommended avenues for health information is having healthcare providers at medical 
clinics or the health departments promote the vaccine, offering the vaccine at local health fairs, 
hosting a health forum, and engaging the local churches to help promote the vaccine. Other 
less commonly recommended health education channels included reaching out to community-
based organizations to promote the vaccine, hosting radio shows about HPV and the vaccine, 
and using both billboards as well as newspapers to promote HPV vaccination. Caregivers’ main 
concerns about health education materials are that the information comes from a credible 
source, provides credible information, and highlights the advantages and disadvantages of the 
vaccine. 
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Discussion 
In rural regions of the state, caregivers’ most commonly cited barrier to the HPV vaccine was 
fear of adverse reactions to the vaccine. Specifically, caregivers feared that the HPV vaccine and 
other adolescent vaccine caused severe adverse reactions such as autism, contained harmful 
ingredients, and are used, experimentally, on children, common controversies related to the 
safety of vaccinations.27 Caregivers were unaware that the most common side effects of the 
vaccine are common to all adolescent vaccines and medical procedures. These side effects 
include pain at site of injection, dizziness, fatigue, fever, and, less common, fainting.28 They 
have received false information about vaccine safety largely from other caregivers via, more 
commonly, blogs, user-generated content.  Blogs are not always the most credible and accurate 
sources of health information, although they may be perceived as credible sources of 
information.29  One review study found that blogs, particularly those who present negative 
information about vaccines, contain incomplete information and lack scientific support such as 
cited references and a bibliography.30 This points to the need for increasing caregivers’ health 
information-seeking skills to be able to locate credible, unbiased health information online. 
Additionally, caregivers cited the role that conservative religious faiths have on HPV vaccine-
related stigma.  Participants’ religious faiths, particularly Mormonism, emphasizes the 
importance of sexual monogamy and waiting until marriage to commence sexual activity.  
Caregivers believed that their adolescent children will follow these ideals, thus making the HPV 
vaccine unnecessary.  HPV vaccination, they believed, may possibly promote sexual debut prior 
to marriage.31 These myths about the HPV vaccine have previously been debunked, and past 
research has found that HPV vaccination does not, in fact, lead to premature sexual activity or 
promiscuity.32,33 Research conducted in the neighboring state of Utah recommends 
collaborating with religious leaders to increase HPV vaccine acceptability and reduce stigma of 
this cancer prevention resource.34 
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Willingness for Children to Receive Pharmacist-administered HPV Vaccine 
This study adds to current HPV vaccine literature by exploring rural caregivers’ willingness to 
have their adolescent children receive vaccines, specifically the HPV vaccine, from community 
pharmacists. While most caregivers were unaware that pharmacists can vaccinate adolescents, 
they were willing to have their children obtain vaccines from this “non-traditional” site as long 
as pharmacists have received proper training to administer the vaccines.  Similar to past 
research, caregivers were unaware that pharmacists and pharmacy interns, nationwide, can 
administer adolescent vaccines other than the flu shot.35 They were also unaware that 
pharmacists’ undergo training and certification prior to being able to administer vaccines.36 
According to Arizona State law (A.A.C. R4-23-411), pharmacists and pharmacy interns must 
complete trainings in vaccination administration and cardiopulmonary resuscitation before they 
are allowed to administer vaccines.  This training program includes information related to 
responding to vaccine adverse events, record-keeping and reporting, vaccine administration, 
and immunology. This state law mandates pharmacists to submit an immunization record to a 
patient’s primary care provider with 48 hours upon administering the vaccine.  Pharmacists 
more often notify primary care providers via fax, and the immunization record provides the 
following information:  name of vaccine, vaccine expiration date, vaccine dose, vaccine 
manufacturer lot number, and the professional information on the professional who 
administered the vaccine. Additionally, pharmacists’ ability to vaccinate adolescents varies by 
patient age, state-by-state basis. In Arizona, for patients under age 13 years old, pharmacists 
can only administer the initial HPV vaccine dose with a prescription from a patient’s primary 
care provider. Pharmacists may administer initial doses for all children over age 14, and they 
are allowed to offer vaccine booster doses for children of any age.37 Although this law is in 
place, health education and communication is needed to promote the pharmacy as a location 
for adolescent vaccination. Future health education interventions can test methods of 
increasing awareness and acceptability of pharmacist-administered adolescent vaccination. 
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Convenience of Pharmacist-administered Vaccine 
Caregivers’ willingness to receive vaccinations from the pharmacy was due to their perception 
of this being a more convenient method of healthcare delivery.  However, concepts of 
“convenience” related to how this healthcare model could save time and money. In terms of 
time, having an additional location (other than a primary care provider) administer the vaccine 
would serve as an additional healthcare venue where their children could receive the HPV 
vaccine.  Having additional options could permit increased vaccination because, particularly in 
medically underserved regions, primary care providers and health departments often have long 
waiting periods for scheduling appointments and waiting lines in the clinic. This resonates with 
past rural health research that identified the following barriers to vaccination: travel distance, 
transportation problems, inability to take time off work, and limited provider networks in rural 
settings.38 Caregivers also believed that the flexible hours of pharmacies (being open after 
working hours and on the weekends) could increase the likelihood of having their adolescent 
children vaccinated, particularly since this method of healthcare delivery would not require an 
appointment and because there may be shorter wait times at the pharmacy. A retrospective 
review of records from a community retail pharmacy between August 2011-July 2012 showed 
that pharmacists more often administered vaccinations during the evenings, weekends, and 
during holidays, all times in which primary care provider offices are less likely to be open.7,39 
Impact of Pharmacist-administered Vaccine on Relationship with Primary Care Provider 
When asked how receiving a vaccine from a community retail pharmacist may impact 
caregivers’ relationship with their PCPs, the vast majority of participants described how this 
would not impact their relationship with their PCP. Caregivers were concerned that pharmacists 
would not provide information or update patients’ primary care providers on the pharmacy-
provided vaccination.22Again, however, based on Arizona state law, pharmacists are required to 
fax a vaccine information sheet to patients’ primary care provider within 48 hours of vaccine 
administration.  However, patients may have incomplete or incorrect information about their 
primary care providers, information that would affect their PCPs’ ability to receive this 
information.  
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Since it has been shown that a strong provider recommendation increases vaccination uptake, 
primary care provider recommendation to get vaccines from pharmacists or providers’ 
prescription to have the vaccine filled at a local pharmacy could increase vaccination.35 Past 
research found that family medicine practitioners are more likely to support pharmacist 
administration of the HPV vaccine as compared to pediatricians, possibly due to their pre-
existing collaborative relationship with prescribing medications for older adults as opposed to 
pediatric patients, alone.36 Further,  family medicine practitioners see the results and long term 
outcomes of persistent infection with HPV.36  In this same study, pediatricians’ main concerns 
about pharmacist-administered adolescent vaccinations were failure to report the vaccine 
administration to the primary care provider, reduced primary care providers’ opportunities to 
screen adolescents for other health issues if they received vaccines outside of the primary care 
clinic, and not monitoring patients for post vaccination side effects.36  
Preferences for Health Education  
In terms of information and content, caregivers in this study preferred to receive information 
from a reputable source. Further, they preferred information that is accurate, easy to 
understand, and content which provides a brief overview of the benefits and potential risks of 
the vaccine. 40 
They preferred methods for receiving health information about the HPV vaccine and about 
pharmacist-administered HPV vaccination, caregivers living in rural areas of the state prefer 
receiving print information such as brochures and informational sheets.  They recommended 
disseminating these information sheets in places such as the post office, particularly their post 
office boxes or community boards at the post office to ensure that community members could 
see this health information. They also believed this information should be disseminated at 
healthcare providers’ offices and at pharmacies. Caregivers were also interested in receiving 
information via a website or through social media, particularly their Facebook community page.  
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Study Limitations 
This qualitative interview study had a small final sample size of 26 respondents, but we reached 
information saturation in terms of large proportions of the respondents echoing similar, 
common themes. Despite recruiting from rural regions across the state of Arizona, the northern 
region of the state was more fully represented. This could have influenced the weight of the 
cited barriers to HPV vaccination since this region tends to be largely socially conservative and 
religious. Additionally, all of the respondents were women, but this is not completely 
unexpected since women are largely the caregivers of adolescents, especially in rural regions of 
the state. 
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Conclusion and Future Directions 
Generally, caregivers of HPV vaccine age-eligible children living in rural and medically 
underserved areas are willing to have their children receive the HPV vaccine from their 
community pharmacists. This creates an additional avenue for HPV vaccination, particularly in 
medically underserved areas in which there are less primary care providers available. This 
healthcare delivery model was deemed more convenient based on the ability to save time and, 
potentially, money by offering this non-traditional location as a vaccination site. Based on 
interview data, pharmacy vaccination programs could be a viable and accepted way to increase 
the vaccination rates in these rural populations without influencing the ways that primary care 
is utilized for healthcare.  Therefore, future research should involve testing an educational 
outreach program coupled with pharmacist-administered vaccines to increase HPV vaccination 
rates specifically in rural regions of Arizona, with hopes of eventually spreading the program’s 
implementation across the US. 
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